000 | 01264 a2200349 4500 | ||
---|---|---|---|
005 | 20250518011054.0 | ||
264 | 0 | _c20190308 | |
008 | 201903s 0 0 eng d | ||
022 | _a1521-0669 | ||
024 | 7 |
_a10.1080/08880018.2018.1539149 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFlores Legarreta, Alejandra | |
245 | 0 | 0 |
_aAnti TNF-α therapy in patients with relapsed and refractory Langerhans cell histiocytosis: a phase II study. _h[electronic resource] |
260 |
_bPediatric hematology and oncology _c |
||
300 |
_a362-368 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial, Phase II; Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 |
_aEtanercept _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHistiocytosis, Langerhans-Cell _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
700 | 1 | _aEckstein, Olive | |
700 | 1 | _aBurke, Thomas M | |
700 | 1 | _aMcClain, Kenneth L | |
773 | 0 |
_tPediatric hematology and oncology _gvol. 35 _gno. 5-6 _gp. 362-368 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1080/08880018.2018.1539149 _zAvailable from publisher's website |
999 |
_c29082874 _d29082874 |